182 related articles for article (PubMed ID: 8661395)
21. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate.
Martín J; LaBranche CC; González-Scarano F
J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346
[TBL] [Abstract][Full Text] [Related]
22. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
[TBL] [Abstract][Full Text] [Related]
23. Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.
Painter SL; Biek R; Holley DC; Poss M
J Virol; 2003 Aug; 77(15):8448-61. PubMed ID: 12857914
[TBL] [Abstract][Full Text] [Related]
24. Epitopes of HIV-1 glycoproteins recognized by the human immune system.
Laal S; Zolla-Pazner S
Chem Immunol; 1993; 56():91-111. PubMed ID: 7680869
[No Abstract] [Full Text] [Related]
25. Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.
Robert-Guroff M; Louie A; Myagkikh M; Michaels F; Kieny MP; White-Scharf ME; Potts B; Grogg D; Reitz MS
J Virol; 1994 Jun; 68(6):3459-66. PubMed ID: 7514675
[TBL] [Abstract][Full Text] [Related]
26. Genotypic and phenotypic characterization of a neutralization-resistant breakthrough population of HIV-1.
Sirko DA; Ehrlich GD
Virology; 1996 Apr; 218(1):238-42. PubMed ID: 8615028
[TBL] [Abstract][Full Text] [Related]
27. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
[TBL] [Abstract][Full Text] [Related]
28. Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies.
Schutten M; Andeweg AC; Rimmelzwaan GF; Osterhaus AD
J Gen Virol; 1997 May; 78 ( Pt 5)():999-1006. PubMed ID: 9152416
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
[TBL] [Abstract][Full Text] [Related]
30. Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions.
Stern TL; Reitz MS; Robert-Guroff M
J Virol; 1995 Mar; 69(3):1860-7. PubMed ID: 7853527
[TBL] [Abstract][Full Text] [Related]
31. Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
Back NK; Smit L; Schutten M; Nara PL; Tersmette M; Goudsmit J
J Virol; 1993 Nov; 67(11):6897-902. PubMed ID: 8411395
[TBL] [Abstract][Full Text] [Related]
32. Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys.
Si Z; Cayabyab M; Sodroski J
J Virol; 2001 May; 75(9):4208-18. PubMed ID: 11287570
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of the V1V2 region of human immunodeficiency virus type 1.
Palmer C; Balfe P; Fox D; May JC; Frederiksson R; Fenyö EM; McKeating JA
Virology; 1996 Jun; 220(2):436-49. PubMed ID: 8661394
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
[TBL] [Abstract][Full Text] [Related]
35. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120.
Moore JP; Cao Y; Qing L; Sattentau QJ; Pyati J; Koduri R; Robinson J; Barbas CF; Burton DR; Ho DD
J Virol; 1995 Jan; 69(1):101-9. PubMed ID: 7527081
[TBL] [Abstract][Full Text] [Related]
36. Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.
Thali M; Charles M; Furman C; Cavacini L; Posner M; Robinson J; Sodroski J
J Virol; 1994 Feb; 68(2):674-80. PubMed ID: 7507184
[TBL] [Abstract][Full Text] [Related]
37. Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies.
Beddows S; Louisirirotchanakul S; Cheingsong-Popov R; Easterbrook PJ; Simmonds P; Weber J
J Gen Virol; 1998 Jan; 79 ( Pt 1)():77-82. PubMed ID: 9460926
[TBL] [Abstract][Full Text] [Related]
38. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.
Morikita T; Maeda Y; Fujii S; Matsushita S; Obaru K; Takatsuki K
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1291-9. PubMed ID: 9339846
[TBL] [Abstract][Full Text] [Related]
39. Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization.
Fouts TR; Trkola A; Fung MS; Moore JP
AIDS Res Hum Retroviruses; 1998 May; 14(7):591-7. PubMed ID: 9591713
[TBL] [Abstract][Full Text] [Related]
40. Herpesvirus saimiri-immortalized human lymphocytes: novel hosts for analyzing HIV type 1 in vitro neutralization.
Vella C; Zheng NN; Easterbrook P; Daniels RS
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):933-46. PubMed ID: 12230936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
